Merete Lund Hetland

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Josef S Smolen, Robert Landewé, J. W. J. Bijlsma et al. · Annals of the Rheumatic Diseases · 2020 · 2.8K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Merete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp et al. · Arthritis & Rheumatism · 2009 · 541 citations

Medicine, Internal Medicine, Pharmacotherapy +14

Health in Old Age: How Do Physicians' Ratings and Self-ratings Compare ?

Asenath LaRue, L. Bank, U. Jarvik et al. · Journal of Gerontology · 1979 · 383 citations

Education, Geriatric Medicine, Health Sciences +15

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Merete Lund Hetland, B Ejbjerg, Søren Jacobsen et al. · Annals of the Rheumatic Diseases · 2008 · 366 citations

Medicine, Clinical Sciences, Immunology +17

FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

Axel Finckh, David Neto, Juan J. Gómez‐Reino et al. · Annals of the Rheumatic Diseases · 2014 · 317 citations

Medicine, Internal Medicine, Pharmacotherapy +15